Evidence map›Paper›PMID 35196792›Full record

ArticleMicrobiology spectrum2022

Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.

Yinyue Li, Bo Wang, Feng Lu, Juhee Ahn, Wenwen Zhang, Liangliang Cai, Jiahui Xu, Yi Yin, Qingchao Cao, Zhenyu Ren and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Machine learning for predictingBioinformation · 2025
    Article
  4. Article
  5. Article
  6. Analysis of carbapenem-resistantInternational journal of molecular epidemiology and genetics · 2024
    Article
  7. Drug design, development and therapy · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Yinyue Li *Department of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Bo Wang *Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
Feng LuDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Juhee AhnDepartment of Medical Biomaterials Engineering, College of Biomedical Science, Kangwon National Universitygrid.412010.6, Chuncheon, Gangwon, South Korea.
Wenwen ZhangDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Liangliang CaiDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Jiahui XuDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Yi YinDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Qingchao CaoDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Zhenyu RenDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.
Xinlong HeDepartment of Pathogen Biology, School of Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, People's Republic of China.ORCID 0000-0003-2894-8250
Yangzhou University · CNAnhui Medical University · CNKangwon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem resistance of Acinetobacter baumannii poses challenges to public health. Biofilm contributes to the persistence of A. baumannii cells. This study was designed to investigate the genetic relationships among carbapenem resistance, polymyxin resistance, multidrug resistance, biofilm formation, and surface-associated motility and evaluate the antibiofilm effect of polymyxin in combination with other antibiotics. A total of 103 clinical A. baumannii strains were used to determine antibiotic susceptibility, biofilm formation capacity, and motility. Enterobacterial repetitive intergenic consensus (ERIC)-PCR fingerprinting was used to determine the genetic variation among strains. The distribution of 17 genes related to the resistance-nodulation-cell division (RND)-type efflux, autoinducer-receptor (AbaI/AbaR) quorum sensing, oxacillinases (OXA)-23, and insertion sequence of IS

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesBiofilmsCeftazidimeDrug Resistance, Multiple, BacterialDrug Therapy, CombinationMicrobial Sensitivity TestsPolymerase Chain ReactionPolymyxin BQuorum SensingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase OXA-23beta-LactamasesCeftazidimeoxacillinasePolymyxin BAcinetobacter baumanniiantibiofilm formationcarbapenem resistancepolymyxin Bquorum sensing

Identifiers

PMID35196792
PMCPMC8865539
OpenAlexW4213414635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.